Prof. Ken Mills is an Emeritus Professor of the  School of Medicine, Dentistry and Biomedical Sciences, Patrick G Johnston Centre for Cancer Research. His interests are in translational research in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) with the aim of improving diagnosis, prognosis, and prediction of therapeutic responses through the identification of novel and repurposed therapies.